Trial 0C-17-12


A Phase 1/2a Study of BMS-986242 Administered in Combination with Nivolumab (BMS--936558, Anti-PD-1) in Advanced Malignant Tumors

Type: Treatment
Phase: Phase I
Status: Not Open (Closed)
Treatments: Immunotherapy
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Anthony El-Khoueiry, M.D.
Other Trial Staff:  Yan Ning, D.M., Jessica Levano, Coordinator, Jubilee Acap, Coordinator, Arthur Alvarez, D.M., Khatchik Karakozian, D.M.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.